Position in RYTM
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$6,478,266
+$5,405,405 QoQ
Shares Held
58,347
+373.0% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#96
of 299 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Derivatives in RYTM
reported options exposure · as of Mar 31, 2023CallValue
$0
CallShares
0
PutValue
$1,784,000
PutShares
100,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. RYTM ranks #54 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in RYTM
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,478,266 | 58,347 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $1,072,861 | 12,336 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,361,547 | 12,720 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,320,948 | 13,080 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $2,168,933 | 34,324 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $4,566,330 | 86,206 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,906,114 | 69,777 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,158,310 | 41,197 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $820,871 | 19,992 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $8,255,231 | 190,520 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,496,170 | 54,300 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,585,126 | 69,144 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $1,452,191 | 88,065 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $1,784,000 | 100,000 | Put | Defined | 2023-05-11 | |
| 2023-03-31 | $6,064,797 | 339,955 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $8,024,336 | 275,561 | Shares | Defined | 2023-02-09 | |
| 2022-12-31 | $2,620,800 | 90,000 | Put | Defined | 2023-02-09 | |
| 2022-09-30 | $3,675,000 | 150,000 | Call | Defined | 2022-11-10 | |
| 2022-09-30 | $2,205,000 | 90,000 | Put | Defined | 2022-11-10 | |
| 2022-09-30 | $6,668,581 | 272,187 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $9,403 | 2,266 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $52,208 | 4,532 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $958,249 | 96,017 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $780,021 | 59,726 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $2,582,582 | 131,899 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $3,242,143 | 152,428 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $262,367 | 8,825 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $160,271 | 7,396 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $520,347 | 23,334 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $304,932 | 20,035 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||